EU Proposes New Guidance On Allergen Products With Small Study Populations
Executive Summary
Current EU guidelines for allergen products require sufficiently large numbers of patients to be included in clinical trials, which is not feasible for products being developed to treat patients suffering from low-prevalence allergies.